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Abstract  
Objectives: To explore the effects of 12 weeks of unsupervised home-based exergaming (i.e. 
technology-driven exercise) compared to usual care on physical function, body composition, 
quality of life (QoL) and fatigue in prostate cancer patients (PCa) on androgen deprivation 
therapy (ADT).  
Patients and methods: In an assessor-blinded randomized controlled trial, 46 PCa patients 
(+65 years of age) with locally advanced or advanced stage disease undergoing ADT were 
randomized to 12 weeks of unsupervised home-based exergaming, or usual care from two 
hospitals in Denmark. The primary outcome of the study was 6-minute walking test (6MWT). 
Secondary outcomes were leg extensor power (LEP), body composition (lean- and fat- mass), 
self-reported physical functioning and global health status (EORTC QLQ-C30), QoL (FACT-
P) and fatigue (FACT-F).  
Results: Significant improvement was seen in the exergaming group compared to the usual 
care group in the primary outcome 6MWT (mean difference: 21.5 meters; 95% confidence 
interval (CI) 3.2 – 39.9; p=0.023). No between group differences were seen for LEP (p= 
0.227), lean body mass (p=0.100), fat body mass (p=0.092), self-reported physical 
functioning (p=0.084) and global health status (p=0.113), QoL (p=0.614) and fatigue 
(p=0.147).   
Conclusion: 12 weeks of unsupervised home-based exergaming had an effect on the primary 
outcome 6MWT in PCa patients receiving ADT. However, no significant effects were found 
in secondary outcomes. The exergaming intervention appeared safe and could be an 
alternative to traditional aerobic and resistance training in this patient group. 
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Introduction 
Androgen deprivation therapy (ADT) constitutes a central component in the treatment of 
metastatic prostate cancer (mPCa) and as adjuvant therapy to radiation in patients with 
intermediate or high-risk localized disease. Unfortunately, ADT has several adverse effects: 
reduced physical function shown by reduced grip strength, and decreased score on the Timed 
Up and Go test [1], Loss of muscle and bone mass [2], decreased (QoL) [3], and increased 
fatigue [4] are frequently observed. Fortunately many of these ADT related complaints 
appear to be counteracted by exercise interventions. Systematic reviews have documented 
beneficial effects of combined aerobic and resistance exercise interventions on ADT-related 
adverse effects in PCa patients [5–9]. However, the majority of exercise studies have been 
conducted in supervised facilities (i.e. a hospital clinic or a fitness centers), making the 
interventions inconvenient to patients due to travel distance and fairly costly due to the 
involved health professionals. Therefore, as an alternative, a few studies have explored home-
based unsupervised walking interventions on PCa patients receiving ADT and have found 
positive results on vitality and body composition [10–12].  
Marked advances in gaming technology, e.g. the introduction of the Nintendo Wii balance 
board in 2008 and the Microsoft Kinect Camera in 2010, has led to a new way of controlling 
and playing games. This new way is by standing up and moving the body in order to control 
an avatar displayed on a television screen and has been labeled “exergaming”. Through 
history computer games have been controlled while sitting down using a handheld controller 
or a keyboard. This new way of exercising called exergaming has already been studied in 
other cancer patients than PCa patients and have shown alleviating fatigue, improving 
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functional performance [13], maintaining physical performance during chemotherapy [14] 
and increasing physical activity during hospitalization [15]. One home-based exergaming 
study in post-surgical lung cancer patients showed reduced fatigue, improved functional 
status and QoL [16]. Thus, in the present study we aimed to explore the effects of 12 weeks 
of unsupervised home-based exergaming in PCa patients receiving ADT compared to usual 
care. The effects were evaluated between the groups primarily through the 6MWT and 
secondary through leg extensor power (LEP), body composition (lean- and fat- mass), 
physical functioning and global health status (EORTC QLQ-C30), and QoL (FACT-P), and 
fatigue (FACT-F).  
 
Material and Methods 
Study Design and Recruitment 
In an assessor-blinded randomized controlled trial 23 patients were assigned to the 
intervention group (Exergaming) and 23 patients to a usual care group. Eligible patients were 
Danish speaking PCa patients receiving continuous ADT for at least three months prior to 
inclusion, cognitively well-functioning and able to answer questionnaires and comply with 
the exercise program according to instruction, and performance status 0-1.  For safety 
reasons, progression of PCa disease or development or progression of bone pain due to bone 
metastases during the intervention period would discontinue patients. Between February 2015 
and January 2017 we included 46 patients from the urological outpatient clinics at Regional 
Hospital Holstebro, (n=32) and Regional Hospital Viborg (n=14), Denmark. All study 
procedures were conducted at Regional Hospital Holstebro. The study was registered at 
Clinical trial.gov, ID: NCT01762241 and approved by the Regional ethical committee 
Central Denmark Region, protocol no. 1-10-72-195-14 as well as by the Danish Data 
Protection Agency protocol no. 1-16-02-536-14. 
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Written informed consent was obtained from all patients prior to inclusion in the study.  
The study protocol has previously been published [17]. Remaining outcomes stated in the 
protocol paper will be published elsewhere. 
 
Sample size calculation 
Based on pilot testing our sample size calculation assumed that the exergaming intervention 
would lead to a between group difference of 100 meter with a standard deviation of 84.5 in 
the 6MWT at 12 weeks follow-up favoring the exergaming group (one-way). Further, we 
based our sample size calculation on an alfa level of 5 % and a beta level of 90 % and a 
dropout rate of 30%. With these assumptions 48 patients needed to be enrolled to attain 34 
completed patients. 
 
Randomization and blinding 
The principal investigator enrolled each subject. Randomization in blocks of 8-10 patients 
was used to secure a balanced allocation of patients (1:1) to either intervention or usual care. 
For randomization purposes, sealed, opaque envelopes with equal allocation to each group 
were used in an amount consistent to the number of subjects randomized in each block. The 
research assistant supervised each subject picking an envelope. All physical and functional 
outcomes were assessed by an experienced physiotherapists blinded to the group allocation.   
 
Intervention 
The intervention group received 90 minutes individual instruction by a physiotherapist prior 
to the homebased exergaming with the Xbox 360 Kinect system (Microsoft, Redmond, WA, 
USA). Patients were instructed to do aerobic and strength exercise for one hour, including a 
warm up and cool down period, three times a week for 12 weeks using the Your Shape 
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Fitness Evolved 2012, Sport and Adventure games at their own convenience. Free weights of 
0.5, 1.0 and 2.0 kg were used to support the gradually increasing exercise intensity of the 
Fitness Evolved 2012 game. Throughout the study, i.e. from baseline to week24 (w24), each 
patient kept a diary of his self-reported exercise. No other study procedures were scheduled 
between w12 and w24. 
Until the post-intervention assessments at w12 the research assistant contacted the 
intervention group by telephone every second week to ensure compliance, registration of 
adverse events, and changes in medication. Between w12 and w24 the patients were not 
contacted by the research assistant.  
Usual care 
Usual care group patients were instructed to continue their normal daily activities throughout 
the study and each patient kept a diary of his self-reported exercise. As the usual care group 
was not expected to increase activity level until the post-intervention assessments at w12, the 
research assistant contacted this group by telephone every fourth week to ensure compliance, 
registration of adverse events, and changes in medication. Between w12 and w24 the patients 
were not contacted by the research assistant.  
At w24 patients in the usual care group were given advice on exercise according to existing 
guidelines, recommending 150 minutes of aerobic exercise of moderate intensity or 75 
minutes of vigorous intensity every week, combined with two sessions of resistance exercise 
and stretching[18]. 
 
Primary and secondary Outcomes 
Primary and secondary outcomes were measured at baseline and at w12 (Table 1).  
The validated 6MWT was used to assess physical function, which was the primary outcome. 
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A power rig (University of Nottingham Medical School, Nottingham, UK) was used to assess 
leg extensor power (LEP). Body composition was assessed using the Bodystat® Quadscan 
4000 bioelectrical impedance analyzer. The physical functioning and global health status 
subscales of the quality of life questionnaire EORTC QLQ-C30 and Functional Assessment 
of Cancer Therapy-Prostate (FACT-P) questionnaires were used to assess self-reported QoL. 
The fatigue subscale of the Functional Assessment of Cancer Therapy - Fatigue (FACT-F) 
questionnaire was used to assess fatigue using a fatigue-defining cut-off score of < 34[19]. 
Godin Leisure-Time Exercise Questionnaire score was used at baseline, w12 and follow-up at 
w24 (intervention group only) to track changes in physical activity level. High score is 
correlated with physical activity and low score reflects physical inactivity. 
Exercise intensity during exergaming as well as physical activity (i.e. accelerometry) was not 
measured. 
 
Statistical analysis 
Data were analyzed using Stata version 13. The primary analysis was a modified intention-to-
treat (mITT) population consisting of individuals with both baseline and w12 measurements. 
We performed a complete case analysis comparing groups according to the original random 
allocation. 
For all outcome measures a linear regression analysis was conducted to evaluate differences 
in effects between groups adjusting for the baseline values as well as treatment duration 
below or above 365 days (ADT), BMI, and activity level based on the Godin Leisure-Time 
Exercise Questionnaire score. All values are shown as the mean and 95 % confidence interval 
(CI). A P value of less than 0.05 was considered to be statistically significant.  
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Results 
As shown in the CONSORT diagram (Figure 1), two patients in the intervention group and 
three patients in the usual care group did not complete the study, resulting in 91% completing 
patients in the intervention group and 87 % in the usual care group. One of the remaining 20 
patients in the usual care group sustained a muscle strain during the physical tests at baseline 
and refused to repeat these tests at post-intervention.  
There were no significant between-group differences at baseline (Table 2). A panel of 
biochemical routine measurements, including plasma potassium, sodium, calcium, albumin-
adjusted calcium, albumin, creatinine, glomerular filtration rate, CO2 and hemoglobin, were 
analyzed and remained stable during the study (data not shown). 
 Neither cardiovascular nor skeletal related events (i.e. pathologic fracture, spinal cord 
compression, necessity for radiation to bone (due to pain or impending fracture) or surgery to 
bone) were observed during the study. 
 
Primary outcome 
At w12, the adjusted analysis for the 6MWT showed a statistically significant difference 
favoring the intervention group, with an estimated 4.2 % improvement of 21.5 meters (95 % 
CI 3.2 to 39.9, p=0.023) compared to the usual care group (Table 3).  
 
Secondary outcomes 
LEP 
The LEP test showed no statistical significant improvement in the intervention group 
compared to the usual care group in the adjusted analysis (mean difference 20.3 w; 95 % CI -
13.2 to 53.8 p= 0.227) (Table 3).   
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Body composition 
At w12 lean mass increased numerically (mean difference 0.91 %; 95 % CI -0.2 to 2.0; 
p=0.100) and fat mass decreased numerically (mean difference -0.9 %; 95 % CI -2.0 to 0.2; 
p=0.092) when comparing the groups (Table 3). However, neither difference reached the 
level of statistical significance.    
 
Quality of life and Fatigue 
After 12 weeks the intervention group had the same QoL (FACT-P) as the usual care group 
(mean difference 2.1 points; 95 % CI -6.3 to 10.6 p=0.614). Numerical, but insignificant 
increases were observed in physical functioning (+7.7 %; mean difference 6.2 points; 95 % 
CI -0.9 to 13.3; p=0.084) and global health status compared to the usual care group (mean 
difference +8.8 points; 95 % -2.2 to 19.7 p=0.113) (Table 3).   
Fatigue did not improve in the intervention group compared to the usual care group at w12 
(mean difference 2.4 points; 95 % CI -0.9 to 5.7 p=0.155) (Table 3).  
The intervention was well-tolerated by all patients. However, when exercising one patient in 
the intervention group experienced severe non-heart-related chest pain due to surgical clips in 
thorax leading to discontinuation from the trial. No other adverse events from the intervention 
led to withdrawal or discontinuation of patients from the study. 
 
Physical activity level  
The Xbox Kinect, games and dumbbells were given to the intervention group to keep, and 
thus we investigated any change in physical activity level in this group after the w12 
assessments. Figure 2 shows that the intervention group voluntarily continued to increase 
physical activity level throughout the study displayed by an increase of 8.5 points on the 
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Godin Leisure-Time Exercise score at w12 and an increase of 15.2 points at w24 compared to 
baseline. However, the increase was not statistically significant. 
Compliance to the intervention is shown in Figure 3. Each patient reported exergaming on 
average 153.5 minutes per week between baseline and w12; however, the protocolled 
exercise duration was 180 minutes per week.   
 
Discussion 
This is the first study to examine the effects of 12 weeks of unsupervised home-based 
exergaming using a Microsoft Xbox 360 Kinect system in PCa patients receiving ADT 
compared to usual care. Our main finding was that the exergaming intervention significantly 
improved the six minutes walking ability compared to the usual care group. Surprisingly, in 
all of our secondary outcomes, we found no significant change between groups. However, we 
did see trends favoring the exergaming group as LEP increased by 7.6 % and fat mass 
decreased by 3.0 % compared to the usual care group. In addition, during the post-
intervention period (from week 12 to 24) we did not expect the exergaming group to continue 
to be physically active, however the Godin score proved otherwise and peaked at week 24. 
Finally, the current exergaming intervention appeared safe in PCa patients on ADT, as no 
incidents of cardiovascular or skeletal related events were reported.  
Walking speed has a potential to predict future health status, functional decline, and 
mortality[20], and as PCa patients can live for decades due to new therapies, the 6MWT 
could be used as a reliable measure in the clinical setting as well as in clinical research when 
health promoting interventions are evaluated. We found a significant difference of 21.5 
meters (p=0.023) between groups favoring the exergaming group in the 6MWT, but a post 
hoc effect size calculation (cohen’s d) showed a small to medium effect. Unfortunately, no 
studies on minimal clinically important difference (MCID) have been performed on PCa 
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patients to place our results in context. However, a recent systematic review by Bohannon et 
al explored MCID in adults with different pathology and found the MCID distance on the 
6MWT to be somewhere between 14.0 to 30.5 meters [21]. With this in mind our 21.5 meters 
might have had a clinical impact on our patients. On the other hand, when comparing our 
results to other studies which have looked at supervised and unsupervised aerobic and/or 
resistance exercise [7,11,22–26] our results appear fairly modest. In example, Gaskin et al 
found a significant increase of 49.98 meters in the intervention group compared to the control 
group [25], and  in the study by Hojan et al [23] the intervention group increased walking 
distance while the control group gradually decreased walking distance leading to an 
improvement of  27.39 meters favoring the intervention group. Thus, the exergaming 
intervention did not reach the same effect on walking distance as supervised aerobic and 
resistance. This might be explained by the design of the study, as there was no supervision 
after the instructions at baseline, and thus the patients did not get any feed-back on their 
exercise level and performance other than what the technology provided. Exergaming 
technology offers some sort of feed-back, reward system and goal-setting and thus motivates 
PCa patients to exercise, which is considered important in cancer rehabilitation [27]. 
However, exertion is a self-perceived phenomenon, and it is unclear whether patients 
performed at their maximum during exergaming without supervision. Nevertheless, patients 
were in contact with a research assistant on regularly basis, and thus the effort put in to 
exergaming could have been influenced positively.    
The lack of ability to show any significant improvement in self-reported physical functioning, 
general health status and FACT-P was supported by findings in previous studies, where 
supervised exercise was demonstrated to be more efficient than home-based exercise [23,28]. 
However, previous conflicting results have been reported with regards to this outcome 
measure [29]. The exergaming intervention showed an improvement of 1.74 % on the FACT-
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P total score, which is less than previous shown 3-10 % improvements in adjusted between 
group differences in aerobic and resistance exercise interventions [28].  As the most 
beneficial exercise intervention to improve the FACT-P score has yet to be clarified, 
exergaming needs further investigations as the technology offers both single-player and 
multiplayer games, where patients can have fun while exergaming together. Thus, it can be 
investigated whether increase in QoL is dependent on, whether patients do exergaming 
together or alone as football due to its group-based nature has shown positive results on 
mental and social well-being [30]. 
The fatigue score was generally high in our patients, implying the absence of fatigue at 
baseline and this may explain that exercise was unable to improve it any further. Most likely, 
the high baseline fatigue score is explained by a selection bias when recruiting study 
participants. We believe the physically demanding intervention attracted primarily physically 
fit patients, as 78 eligible patients refused to participate.  
Contrary to previous findings [31,32] the effect on body composition was negligible. We 
believe this reflects an insufficient intervention with regard to resistance exercise as well as 
the lack of continually reminding the patients about the progressive demand to perform 
moderate to high intensity exercise. In addition, exercise intensity is a subjective experience 
and some patients might not have challenged themselves as much as an exercise physiologist 
or physiotherapist would have done in a supervised setting. Especially the patients with bone 
metastases might have exercised more careful in respect of sustaining a fracture or injury 
when left on their own. 
The observed numerically increase in leg muscle power in the intervention group was less 
than reported in supervised exercise studies [28], presumably due to factors as described 
above.    
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The documented average minutes spent exergaming per week did not comply with the 
protocolled 180 minutes. Thus it is unknown whether the reporting was unreliable or a true 
inadequate compliance explained by lack of interest, priority or a too demanding intervention.  
As previously published [33] and recommended by Kahan et al [34], our analysis were 
adjusted to minimize any confounding impact on the outcomes, since randomization does not 
guarantee balance in important baseline covariates. In particular, we had expected physical 
activity to be a pronounced prognostic factor, however, this covariate turned out to be 
balanced at baseline (Table 2).  
The very low attrition rate, with 91% completing patients in the intervention group and 87% 
in the usual care group, implies an applicable study design for use in future studies. 
Nevertheless, a few limitations need to be taken into account in this study. The true effect of 
21.5 meters was less pronounced than the estimated 100 meters increase in the intervention 
group compared to the usual care group. However, this estimate was unrealistic to reach as it 
presumably would have demanded changes in walking technique (i.e. posture, stride and arm 
motion) in addition to exergaming. Though, the statistical significant result of the 6MWT 
needs to be confirmed in larger multicenter studies, as  the risk of type II error increased in 
this study. The sample size of 46 patients was based on the expectation that it would be 
unrealistic to recruit a significantly large study population within the actual time frame. 
Another limitation, well-known in exercise trials, is that the current study was unavoidably 
affected by a selection bias. Firstly, the consent to participate required a surplus of mental 
and physical energy. This notion was supported by the high baseline score on the fatigue 
subscale and accordingly, our data cannot be extrapolated to more severely affected PCa 
patients. Secondly, all patients were from rural and urban areas, most of them married and 
holding a bachelor degree, making the study population quite homogenous but concurrently 
less representative for the entire background population of PCa patients.  
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Conclusions 
To the best of our knowledge, this is the first randomized study to investigate the effects of 
unsupervised home-based exergaming in PCa patients undergoing ADT. The study showed a 
significant but modest improvement in 6MWT favoring the exergaming group. In addition, 
results showed that the intervention group kept being physically active during the post-
intervention period, where no influence from health care professionals was present. In 
addition, no significant effects in any of the secondary outcomes were found. The 
exergaming intervention appeared safe and could be an alternative to traditional aerobic and 
resistance training in this patient group.  
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Legends to figures and tables: 
 
Figure 1 - CONSORT diagram of recruitment and loss to follow-up through the trial 
One patient in the intervention group developed non-cardiac related chest pain during 
exercise and one withdrew consent. In the control group one patient violated the allocated 
intervention, one suffered a severe traffic accident, and another did not accept the allocated 
intervention.   
 
Figure 2 – Mean score on the Godin Leisure-Time Exercise Questionnaire 
Mean score on the Godin Leisure-Time Exercise questionnaire reflecting physical activity 
level throughout the study. Only data on the exergaming group at 24 weeks follow-up. 
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Figure 3 – Average minutes spent exercising per week for all patients in the exergaming 
group. 
 
Table 1 – Assessment schedule 
All assessments were conducted at three time points over the course of six months. 
At baseline patients allocated to the intervention group attended the clinic an additional two 
times for instructions regarding the home-based exercise program. 
 
Table 2 – Baseline characteristics of study participants 
ADT=Androgen Deprivation Therapy.  
Data for continuous variables were assessed as Mean (SD) using independent sample t-test.  
Non-normal distributed continuous data were assessed as median (IQR) using Mann-Whitney 
test. 
Data for categorical variables are presented as frequency (%) using Fisher’s exact test. 
There were no statistical significant differences between groups at baseline (p > 0.05 for all 
variables). 
T stage was determined at time of PCa diagnosis. The presence of metastases was determined 
when ADT was initiated. 
 
Table 3 – Between group changes adjusted for baseline score on the Godin Leisure-
Time Exercise Questionnaire, ADT treatment duration </> 365 days and BMI 
*Baseline data was not available from one withdrawn patient in the usual care group. 
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Table 1 – Assessment schedule 
All assessments were conducted at three time points over the course of six months. 
At baseline patients allocated to the intervention group attended the clinic an additional two 
times for instructions regarding the home-based exercise program. 
 
 Week -2/baseline Week 0-12 Week 12 Week 24 
 
Inklusion and 
randomization 
x    
Assessments: 
6MWT 
LEP 
Body composition 
 
 
x 
x 
x 
  
x 
x 
x 
 
Questionnaires: 
EORTC QLQ C-30 
scales: Physical 
functioning and 
General Health 
status. 
FACT-P 
FACT-F 
 
 
x 
 
x 
x 
x 
  
 
x 
 
x 
x 
x 
 
Godin Leisure-
Time exercise 
questionnaire* 
 
x  x x 
Exergaming three 
times per week/180 
min. 
(intervention 
group) 
 
Usual activity level 
(usual care group) 
 
 x 
 
 
 
x 
  
*At week 24 the Godin Leisure-Time exercise questionnaire was handed out to the 
intervention group only. 
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Table 2 – Baseline characteristics of study participants 
 Intervention group Usual care group 
 (n=23) (n=23) 
 mean + (sd) 
n (%)  
median (IQR) 
 
 
mean + (sd) 
n (%)  
median (IQR) 
Age 
Marital status: 
  Single 
  In relationship, not  
    married 
  Married 
  Divorced 
Educational level: 
  Primary school 
  High school 
  Short-length higher 
    education 
  Medium-length   
    higher education 
  University degree 
Weight (kg) 
BMI 
Waist circumference (cm) 
Gleason score: 
  Gleason 6 
  Gleason 7 
  Gleason 8-10 
67.6 (4.6) 
 
4 (17 %) 
0 (0 %) 
 
18 (78 %) 
0 (0 %) 
 
1 (4 %) 
1 (4 %) 
5 (22 %) 
 
14 (61 %) 
 
2 (9 %) 
93.2 (11.4) 
29.8 (0.6) 
110.1 (8.4) 
 
1 (4 %) 
11 (48 %) 
11 (48 %) 
69.8 (4.4) 
 
3 (13 %) 
2 (9 %) 
 
18 (78 %) 
1 (4 %) 
 
0 (0 %) 
2 (9 %) 
6 (26 %) 
 
14 (61 %) 
 
1 (4 %) 
88.3 (12.1) 
29.1 (0.7) 
109.6 (9.6) 
 
3 (13 %)  
5 (22 %) 
14 (61 %) 
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  Not available 
T-Stage: 
  T1c-T2a 
  T2b 
  T2c-T3c 
  Tx 
Metastases 
  Bone metastases 
  Lymph node metastases 
  M0, prior radiation  
    therapy + ADT 
ADT < 365 days 
ADT > 365 days 
Cardiovascular disease 
PSA (µg/L) 
Godin score 
0 (0 %) 
 
6 (26 %) 
5 (22 %) 
12 (52 %) 
0 (0 %) 
 
10 (43 %) 
2 (9 %) 
11 (48 %) 
 
7 (30 %) 
16 (70 %) 
16 (70 %) 
0,1 (0.1-0.3) 
29.3 (29.2) 
 
 
 
1 (4%) 
 
1 (4 %) 
2 (9 %) 
19 (83 %) 
1 (4 %) 
 
6 (26 %) 
1 (4 %) 
16 (70 %) 
 
8 (35 %) 
15 (65 %) 
17 (74 %) 
0.1 (0.1-0.2) 
27.3 (21.8) 
 
 
 
ADT=Androgen Deprivation Therapy.  
Data for continuous variables were assessed as Mean (SD) using independent sample t-test.  
Non-normal distributed continuous data were assessed as median (IQR) using Mann-Whitney 
test. 
Data for categorical variables are presented as frequency (%) using Fisher’s exact test. 
There were no statistical significant differences between groups at baseline (p > 0.05 for all 
variables). 
T stage was determined at time of PCa diagnosis. The presence of metastases was determined 
when ADT was initiated. 
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Table 3 – Between group changes adjusted for baseline score on the Godin Leisure-Time Questionnaire, ADT treatment duration     
</> 365 days and BMI 
           
 
                    Baseline                    Week 12 Adjusted group differences in 
mean change over 12 weeks 
 
 
Intervention 
group (n=23) 
Usual care 
group 
(n=23) 
Intervention 
group (n=21) 
Usual care 
group 
(n=20) 
 
Mean (SD) 
 
Mean (SD) 
 
Mean (SD) 
 
Mean (SD) 
 
Mean       95%CI       p-value 
 
6-min walk test (m) 
Leg extensor power (w) 
Lean mass (%) 
Fat mass (%) 
 
Physical functioning (points) 
Global health status (points) 
526.8 (65.6) 
319.3 (102.4) 
71.1 (3.6) 
28.9 (3.6) 
 
89.3 (9.8) 
67.0 (20.2) 
497.3 (79.8) 
267.3 (108.2) 
70.6 (3.7) 
29.4 (3.7) 
 
86.4 (12.0) 
67.4 (23.4) 
556.1 (59.0) 
349.2 (93.0) 
71.2 (3.9) 
28.8 (3.9) 
 
93.7 (9.8) 
81.4 (16.9) 
500.8 (80.6) 
272.3 (95.8) 
70.0 (4.3) 
30.0 (4.3) 
 
83.3 (18.8) 
72.5 (20.4) 
21.5                 
20.3                
0.91                
-0.9    
 
6.2      
8.8     
3.2 – 39.9               
-13.2 – 53.8            
-0.2 – 2.0                 
-2.0-0.2                   
 
-0.9 – 13.3              
-2.2 – 19.7    
0.023 
0.227 
0.100 
0.092 
 
0.084 
0.113 
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*FACT-P questionnaire (points) 
FACT-F subscale (points) 
 
118.7 (14.2) 
43.8 (5.4) 
 
 
119.4 (17.4) 
41.1 (8.6) 
 
 
123.1 (13.9) 
45.9 (6.7) 
 
 
120.7 (18.0) 
40.0 (10.3) 
 
 
2.1                  
2.4                   
-6.3 – 10.6    
-0.9 - 5.7                                                                              
0.614 
0.155
 
 
* Baseline data was not available from one withdrawn participant in the usual care group 
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Figure 1 - CONSORT diagram of recruitment and loss to follow-up through the trial 
One patient in the intervention group developed non-cardiac related chest pain during 
exercise and one withdrew consent. In the control group one patient violated the allocated 
intervention, one suffered a severe traffic accident, and another did not accept the allocated 
intervention.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Assessed for eligibility (n=1379) 
Excluded  (n=1333) 
   Not meeting inclusion criteria (n=1241) 
   Declined to participate (n=78) 
   Other reasons (n=41) 
Completed week 12 assessments (n=21). 
Complete case analyses (n=21) 
Lost to follow-up (n=2)  
Withdrawal of consent (n=1). Non-cardiac related 
chest pain (n=1) 
Allocated to intervention (n=23) 
 Received allocated intervention (n=23) 
 Did not receive allocated intervention (n=0) 
Lost to follow-up (n=3)  
Withdrawal of consent (n=1). Excluded (n=2) 
Allocated to usual care (n=23) 
 Received allocated intervention (n=22) 
 Did not receive allocated intervention (n=1) 
   (withdrawal of consent) 
Completed week 12 assessments (n=20). 
Complete case analyses (n=20) 
 
 
Allocation 
Analysis 
Follow-Up 
Randomized (n=46) 
Completed week 24 assessments (n=21). 
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